EMA panel issues negative opinion on Omeros narsoplimab application

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. USO
6. NUAI
7. MSFT
8. ACN
9. AMZN
10. FFAI

Go back to EMA panel issues negative opinion on Omeros narsoplimab application
Omeros Corporation (NASDAQ: OMER) Delayed: 18.20 +0.33 (1.85%)
Previous Close $17.87    52 Week High $16.80 
Open $18.23    52 Week Low $7.20 
Day High $18.29    P/E N/A 
Day Low $17.82    EPS $-1.64 
Volume 90,602